Cargando...

Are there different evidence thresholds for genomic vs. clinical precision medicine? A VOI-based framework applied to antiplatelet drug therapy

OBJECTIVE: To evaluate evidence thresholds for clinically-guided precision medicine (PM) vs. genomically-guided PM. METHODS: We develop an “evidence threshold criterion” (ETC) that is the time-weighted difference between expected value of perfect information (EVPI) and incremental net health benefit...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Value Health
Main Authors: Guzauskas, Gregory F., Basu, Anirban, Serbin, Michael, Carlson, Josh J., Veenstra, David L.
Formato: Artigo
Idioma:Inglês
Publicado: 2019
Assuntos:
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6746330/
https://ncbi.nlm.nih.gov/pubmed/31511188
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jval.2019.03.023
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!